Introduction: For ordinary people, learning the way to make a fortune from successful people to master the wealth code is a practical way, just the so-called standing on the shoulders of giants to see farther, we studied the entrepreneurial stories of hundreds of billionaires, found that they are all a combination of wisdom, diligence, courage and opportunity. On whether it is possible to measure a person's success with more money and less money, the answer is that the wise and the wise depend on the different values of each person, but life cannot only exist in the ideal, and when we return to reality, money still occupies a pivotal position.
Ganzhou is located in the south of Jiangxi Province, is the southern gate of Jiangxi to the Liangguang region, and is also a provincial sub-central city, a national regional central city and an important national transportation hub in Jiangxi Province.
On the 18th of this month, that is, yesterday, boss research agency learned from the official website of the Shanghai Stock Exchange that Maiwei Biotechnology Co., Ltd. (hereinafter referred to as Maiwei Biotechnology Co., Ltd.), a high-tech enterprise founded by Mr. Tang Chunshan, a businessman from Ganzhou, successfully passed the IPO review link of the Shanghai Stock Exchange and was officially listed on the Science and Technology Innovation Board on the same day, stock code: 688062.
After reading the listing prospectus of Maiwei Biologics, BOSS Research Agency shows from the information disclosed by It that Maiwei Biologics intends to publicly issue 99.9 million shares at a unit price of 34.8 yuan per share, of which 14.985 million shares are strategic placements, raising 3.47652 billion yuan. Yesterday morning at the opening, Maiwei Biological stock price broke, and finally closed at 24.5 yuan / share, down 29.6% from the issue price, but today, Maiwei Biological stock price ushered in a strong rebound, as of press time, Maiwei Biological stock price stayed at 31.9 yuan / share, up 30.2% from yesterday's closing price, the company's total market value reached 12.747 billion yuan.
Maiwei Biologics was registered and established in Shanghai Free Trade Zone on May 12, 2017, and after less than five years of development, it has now grown into an innovative biopharmaceutical company with a whole industry chain layout, among which in the therapeutic fields of autoimmunity, oncology, metabolism, ophthalmology, infection and other therapeutic fields, Maiwei Biologics has reached the international leading level.
Mai Wei Bio
We also learned from the information disclosed in the prospectus of Maiwei Biologics that before the public offering of shares, Mr. Tang Chunshan, the chairman of the company, held 37.482%, 0.592%, 0.101% and 0.134% of the shares of Maiwei Biologics through the four limited partnerships of Langrun Equity, Longrun Consulting, China SCE Jianlong and Zhenzhu Investment, and his wife Ms. Chen Shanna held 9.371% and 0.078% of the shares of Maiwei Biologics through Langrun Equity and Longrun Consulting respectively. The total shareholding ratio of the husband and wife has reached 47.758%, the controlled equity has reached 56.51%, and they have absolute control over Maiwei Biologics.
Therefore, based on today's closing price, the value of Tang Chunshan and Chen Shanna soared by nearly 6 billion yuan overnight.
Map of the shareholding structure of Maiwei Biotech
So, who is Tang Chunshan?
According to public information, Tang Chunshan, a native of Anyuan County, Ganzhou City, Jiangxi Province, was born in 1969, is now 53 years old, and has a bachelor's degree. After graduating from university, Tang Chunshan was assigned to work in Baoshan Iron and Steel Co., Ltd. in Shanghai, became an ordinary technician, in the early 90s, Tang Chunshan resigned from the stable job of state-owned enterprises, went to Hainan Province, which had just been established as a special economic zone, to pan for gold, in 1994, Tang Chunshan founded Hainan Weiqi Pharmaceutical Co., Ltd. in Hainan, began his own entrepreneurial road, and then he successively participated in the establishment of Jiangxi Shanxiang Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd. and other enterprises. With extensive work experience in the field of biopharmaceuticals, Tang Chunshan founded Maiwei Biologics in Shanghai in 2017, and under his leadership, it has now developed into a leading high-tech enterprise in the field of biopharmaceuticals. In addition, Tang Chunshan is currently the vice president of the Jiangxi Provincial Chamber of Commerce and the president of the Hong Kong Ganzhou Chamber of Commerce.
Tang Chunshan
Ganzhou has been a place of excellence since ancient times, and there are countless celebrities in the business world, who have created one business legend after another throughout the country with their wisdom and sweat, and we also hope that these outstanding entrepreneurs can actively give back to their hometowns after they become famous, and contribute more to the urban development of Ganzhou, so as to give back to this land that nurtures themselves.
All pictures come from the Internet, it is impossible to determine the copyright ownership, the content of this article is not for commercial purposes, if there is infringement, please contact the author to delete or replace. The content of this article is the original author of the headline number "BOSS Research Society", refuse to reprint, thank you for cooperation, plagiarism must be investigated.